Author:
Rostami Tahereh,Alijani Neda,Kiumarsi Azadeh,Rad Soroush,Mirhoseini Seied Amirhosein,Rostami Mohammadreza,Hesabi Amir,Mousavi Seyed Ali,Mousavi Seied Asadollah, , , , , , , , ,
Reference20 articles.
1. Glucose–6–phosphate dehydrogenase deficiency in India
2. Mukherjee MB, Colah RB, Martin S, Ghosh K. Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India - Country scenario. Indian J Med Res. 2015; 141 (5): 516-20.
3. Glucose-6-phosphate Dehydrogenase Deficiency and Malaria: Cytochemical Detection of Heterozygous G6PD Deficiency in Women
4. Pharmacogenomics of COVID-19 therapies
5. 6 fda.gov [internet]. Food and Drug Administration. FDA Drug Safety Communication: FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems; c2020. [cited 2021 Nov 02]. Available from: https://www.fda.gov/media/137250/download.